ACIU Top Biotech Pick for 2019
AC Immune SA (ACIU)
- This is a Switzerland-based company with focused on neurodegenerative diseases.
- With no treatmeant to Alzheimer's disease is my main reason to invest in this stock. High risk vs high reward.
- Two recent news partnership/collaboration with Lilly and WuXi Biologics.
- Catalyst 2019/2020 data.
- Price Target $20.00+ is my personal target.
- Do you own due diligence.
Disclosure. I am long.
Unexpected bad news came out today, discontinuation of Phase 3 data. I took a loss -55% on the position. This is part of the biotech investment, unfortunate unforeseen event.